pyrroles has been researched along with Cardiomyopathy, Congestive in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banach, M; Bielecka-Dabrowa, A; Mikhailidis, DP; Rizzo, M; Rysz, J; von Haehling, S | 1 |
| Jin, R; Liu, M; Wang, F; Wang, Y | 1 |
| Parker, T | 1 |
| Banach, M; Bielecka-Dabrowa, A; Goch, JH; Maciejewski, M; Mikhailidis, DP; Rysz, J | 1 |
| Aronow, WS; Banach, M; Bielecka-Dabrowa, A; Desai, R; Goch, JH; Maciejewski, M; Rysz, J | 1 |
| Fujii, M; Horie, M; Ibe, K; Kawahara, C; Nakae, I; Sakai, H; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
| Badziński, A; Dyrbuś, K; Mercik, G; Nowak, J; Nowalany-Kozielska, E; Poloński, L; Rozek, MM; Szyguła-Jurkiewicz, B; Wilczek, K; Wodniecki, J; Wojnicz, R; Zembala, M | 1 |
| Carr, AN; Dorn, GW; Hahn, H; Hambleton, M; Hewett, TE; Kimball, TF; Klevitsky, R; Koch, WJ; Kuhn, MC; Molkentin, JD; Pleger, ST | 1 |
| Fukunami, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Node, K; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T | 1 |
6 trial(s) available for pyrroles and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Cardiomyopathy, Dilated; Cytokines; Female; Follow-Up Studies; Heptanoic Acids; Hospitalization; Humans; Inflammation; Male; Middle Aged; Pyrroles; Uric Acid; Ventricular Function, Left | 2013 |
Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Cardiomyopathy, Dilated; Cholesterol; Double-Blind Method; Endothelium, Vascular; Exercise; Exercise Test; Female; Heart Function Tests; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Pyrroles; Vasodilation; Ventricular Function, Left; Young Adult | 2009 |
The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
Topics: Aged; Atorvastatin; Cardiomyopathy, Dilated; Exercise Test; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-10; Interleukin-6; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pyrroles; Time Factors; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2009 |
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.
Topics: Adult; Aged; Atorvastatin; Atrial Fibrillation; Body Mass Index; Cardiomyopathy, Dilated; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles; Tumor Necrosis Factor-alpha | 2010 |
Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
Topics: Aged; Atorvastatin; Cardiomyopathy, Dilated; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Pyrroles; Radionuclide Imaging; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Sympathetic Nervous System; Time Factors | 2011 |
Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
Topics: Adult; Atorvastatin; Cardiomyopathy, Dilated; Cholesterol, LDL; Drug Therapy, Combination; Endpoint Determination; Evaluation Studies as Topic; Female; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunohistochemistry; Male; Myocardium; Pyrroles; Quality of Life; Treatment Outcome; Ventricular Function, Left | 2006 |
3 other study(ies) available for pyrroles and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Case of the month. Idiopathic dilated cardiomyopathy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Clopidogrel; Diuretics; Dyspnea; Echocardiography; Electrocardiography; Furosemide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Propanolamines; Pyrroles; Spironolactone; Ticlopidine | 2009 |
Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure.
Topics: Animals; Calcium; Cardiac Output, Low; Cardiomyopathy, Dilated; DNA; Enzyme Activation; Female; Gene Expression Regulation; Genetic Therapy; Indoles; Male; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction | 2006 |
Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cardiomyopathy, Dilated; Cardiovascular Agents; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Ventricular Remodeling | 2006 |